First in Man Aer-O-Scope
- Conditions
- Screening Colonoscopy for Low Risk Subjects
- Interventions
- Biological: screening colonoscopy
- Registration Number
- NCT02102412
- Lead Sponsor
- GI View Ltd.
- Brief Summary
A single center study intended to evaluate the Aer-O-Scope Colonoscope System.
- Detailed Description
A clinical study in Zagreb Croatia, intended to evaluate the Aer-O-Scope Colonoscope System. The study includes 120 subjects and has the following endpoints:
Evaluation of the Aer-O-Scope advancement, imaging and retraction throughout the Colon.
Safety: No occurrence of any device related major adverse event (for details see section 9.5)
Efficacy:
1. Advancement of device towards the ceacum and retraction
2. Visualization of the colon mucosa by the traveling imaging device
3. Procedure duration
4. Handling and operation (assessment by operator)
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 101
- Healthy volunteers between 18 and 65 years of age.
- Sign informed consent.
- Subjects with any known GI related symptoms complaints or GI diseases.
- Subjects with cancer or other life threatening diseases or conditions.
- Pregnant women.
- Subjects who underwent any abdominal surgery.
- Morbid Obesity (BMI > 40).
- Drug abuse or alcoholism.
- Bed-ridden subject.
- Inadequate communication with the subject.
- Subjects under custodial care.
- Participation in any clinical study within the last 30 days.
- Subjects with known cardiovascular and pulmonary diseases.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description single arm screening colonoscopy single arm patients underwent colonoscopy with aer-o-scope followed by conventional colonoscopy to assess if any mucosal damage occurred with the experimental device.
- Primary Outcome Measures
Name Time Method Ability to traverse the colon using the aer-o-scope under 60 minutes a propulsion system using low pressure co2 gas and balloons is used to propel the system through the colon
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rebro Hospital
ðŸ‡ðŸ‡·Zagreb, Croatia